Live Breaking News & Updates on Alvogen inc

Stay informed with the latest breaking news from Alvogen inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Alvogen inc and stay connected to the pulse of your community

Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP

The Federal Circuit handed down an opinion last week that invalidated several asserted claims and found infringement under 35 U.S.C. § 271(e)(2) of the claims, while refusing to modify...

United-states , Amneal-pharms , Grunenthal-gm , Pfizer-inc , Norwich-pharmaceuticals-inc , Tech-inc , Us-gypsum-co , Llcand-acorda-therapeutics-inc , Watson-labys-inc , Alvogen-inc , Amstar-corp , District-court

Federal Circuit Affirms Obviousness of Rifaximin Polymorph Patents and Denial of Motion to Modify Judgment After Post-Trial Patented Indication Carve Out | Mintz - Intellectual Property Viewpoints

In a precedential opinion issued on April 11, 2024 in Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc., Nos. 22-2153, 23-1952, the U.S. Court of Appeals for the Federal...

Delaware , United-states , Richardg-andrews , Alvogen-inc , Salix-pharmaceuticals-ltd , Alkemlaboratories-ltd , Norwich-pharmaceuticals-inc , Us-court , Us-district-court , Salix-pharmaceuticals , Pharmaceuticals-inc

Federal Circuit Affirms Polymorph Patent Ruling

Federal Circuit Affirms Polymorph Patent Ruling
natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.

Delaware , United-states , Richardg-andrews , Us-court , Laboratories-ltd , Us-district-court , Salix-pharmaceuticals-ltd , Alvogen-inc , Norwich-pharmaceuticals-inc , Salix-pharmaceuticals , Pharmaceuticals-inc

CAFC Panel Splits on Reasonable Expectation of Success Analysis

In a precedential decision authored by Judge Lourie, the U.S. Court of Appeals for the Federal Circuit affirmed a district court’s final judgment that certain claims of several patents owned by Salix Pharmaceuticals for a drug used to treat irritable bowel syndrome (IBS) and other ailments were invalid as obvious.

Delaware , United-states , America , Tiffany-cunningham , Salix-pharmaceuticals , Alvogen-inc , Us-court , United-states-district-court , Bausch-health-companies-inc , Drug-administration , Alkem-laboratories-ltd , Judge-lourie

NRx Pharmaceuticals Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

RADNOR - NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that the Company has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar...

Massachusetts , United-states , France , French , Jonathan-javitt , Matthew-duffy , Andrew-nierenberg , Jeremy-feffer , Exchange-commission , Nasdaq , Lotus-pharmaceuticals-inc , Lotus

NRx Pharma Achieves Data-lock In Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study

Biopharmaceutical company NRx Pharmaceuticals, Inc. (NRXP) announced Monday that it has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study with NRX-101.

Alvogen-inc , Lotus-pharmaceuticals-inc , Nrx-pharmaceuticals-inc , Treatment-resistant-bipolar-depression-study , Lotus-pharmaceuticals , Breakthrough-therapy-designation , Fast-track-designation , Biomarker-letter , Special-protocol-agreement , Suicidal-treatment-resistant-bipolar ,

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Jonathan-javitt , Andrew-nierenberg , Nrx-pharmaceuticals , Alvogen-inc , Nrx-pharmaceuticals-inc , Nasdaq , Nrxp-nrx-pharmaceuticals , Lotus-pharmaceuticals-inc , Treatment-resistant-bipolar-depression-study , Lotus-pharmaceuticals

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , France , Paris , France-general- , Americans , American , French , Marion-leboyer , Stephen-willard , Michael-grunebaum , Mocrane-abbar , Janet-rehnquist

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announces...

France , United-states , Americans , French , Stephen-willard , Nasdaq , Therapeutics-inc , Nrx-pharmaceuticals , Us-national-institutes-of-health , Us-patient-centered-outcomes-research-initiative , Alvogen-inc , Nephron-pharmaceuticals

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT

Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend
RADNOR, Pa., March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a...

France , United-states , Americans , French , Stephen-willard , Nasdaq , Therapeutics-inc , Nrx-pharmaceuticals , Source-nrx-pharmaceuticals-inc , Securities-exchange , Us-national-institutes-of-health , Us-patient-centered-outcomes-research-initiative